Lack of difference among progestins on the anti-atherogenic effect of ethinyl estradiol: a rabbit study

Authors: Peter Alexandersen1; Jens Haarbo1; Pieter Zandberg2; Jørgen Jespersen1; Sven O. Skouby1; Claus Christiansen1

Source: Human Reproduction, Volume 18, Number 7, July 2003 , pp. 1395-1403(9)

Publisher: Oxford University Press

Key:
Free Content - Free Content
New Content - New Content
Subscribed Content - Subscribed Content
Free Trial Content - Free Trial Content

Abstract:

BACKGROUND: Progestins in combination with estrogen are believed to have different effects on the cardiovascular system. The aim of this study was to investigate the influence of different oral contraceptive formulations on the development of experimental atherosclerosis and vascular reactivity. METHODS: A total of 160 sexually mature rabbits were ovariectomized and randomly assigned to equally large groups: (i) a cholesterol-rich diet (320 mg/day), either given alone (placebo), or together with (ii) ethinyl estradiol (EE 70 µg/day, oral), (iii) desogestrel (DSG 525 µg/day, oral), (iv) gestodene (GSD 262.5 µg/day, oral), (v) levonorgestrel (LNG 525 µg/day, oral), (vi) EE + DSG, (vii) EE + LNG, or (viii) EE + GSD. After 31 weeks of treatment, aortic accumulation of cholesterol and vascular vasoreactivity (in vitro) were determined. RESULTS: Progestins alone did not reduce the accumulation of cholesterol. EE alone or in combination with a progestin reduced the accumulation of cholesterol relative to placebo (P < 0.0001). Isolated vessels from EE-treated animals relaxed significantly more to physiological concentrations of acetylcholine than did placebo (P < 0.001), whereas vessels treated with EE plus a progestin showed an intermediate response. CONCLUSION: The progestins investigated can be combined with EE without attenuating the anti-atherogenic effect of EE.

Keywords: atherosclerosis/estrogen/progestins/rabbits/vascul

Document Type: Research article

DOI: 10.1093/humrep/deg286

Affiliations: 1: Center for Clinical & Basic Research, Ballerup Byvej 222, 2750 Ballerup, Denmark and 2: Department of Vascular Pharmacology, N.V.Organon, Molenstraat 110, 5340 BH Oss, The Netherlands

The full text electronic article is available for purchase. You will be able to download the full text electronic article after payment.

$40.03 plus tax      Refund Policy

 

OR

Back to top

Key:
Free Content - Free Content
New Content - New Content
Subscribed Content - Subscribed Content
Free Trial Content - Free Trial Content
Share this item with others: These icons link to social bookmarking sites where readers can share and discover new web pages.
Page Help Click here for Page Help
Shopping cart
Tools
Sign in






Need to register?
Sign up here
Text size: A | A | A | A